EX-FILING FEES 4 ea154809ex-fee_meihuainter.htm FILING FEE TABLE

Exhibit 107

 

Calculation of Filing Fee Tables

 

F-1
(Form Type)

 

Meihua International Medical Technologies Co., Ltd.

(Exact Name of Registrant as Specified in its Charter)

 

Table 1: Newly Registered and Carry Forward Securities

 

    Security Type   Security
Class
Title
  Fee
Calculation
or Carry
Forward Rule
  Amount
Registered
  Proposed
Maximum
Offering Price
Per Unit(1)
  Maximum
Aggregate
Offering Price(2)
  Fee Rate   Amount of
Registration Fee
  Carry
Forward
Form Type
  Carry
Forward
File Number
  Carry
Forward
Initial
effective date
  Filing Fee
Previously Paid
In Connection
with Unsold
Securities
to be Carried
Forward
 
Newly Registered Securities
Fees to Be Paid   Equity   Ordinary Shares   457(o)     5,750,000(3)      10.00    $ 57,500,000     .0000927   $ 5,330.25                          
Fees Previously Paid                                       $ 7,527.90                           
Carry Forward Securities
Carry Forward Securities                                                                    
  Total Offering Amounts   $ 57,500,000         $ 5,330.25                          
    Total Fees Previously Paid               $ 7,527.90                          
    Total Fee Offsets                                          
    Net Fee Due               $ 0                          

 

(1) There is no current market for the securities or price at which the shares are being offered. Estimated solely for the purpose of determining the amount of registration fee in accordance with Rule 457(o) under the Securities Act of 1933, as amended (the “Securities Act”).

 

(2) Pursuant to Rule 416 under the Securities Act, there is also being registered hereby such indeterminate number of additional Ordinary Shares of the Registrant as may be issued or issuable because of stock splits, stock dividends, stock distributions, and similar transactions.

 

(3) Includes (a) 5,000,000 ordinary shares; and (b) up to 750,000 ordinary shares that may be purchased by the underwriters pursuant to their over-allotment option to purchase additional shares.